Drug Profile
LY 2245461
Alternative Names: LY2245461Latest Information Update: 29 Mar 2012
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Developer Chorus Group
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hot flashes
Most Recent Events
- 28 Mar 2012 Discontinued - Phase-II for Hot flashes in Denmark (unspecified route)
- 21 Jul 2008 Chorus Group completes a phase II trial in Hot flashes in Denmark
- 21 Apr 2008 Phase-II clinical trials in Hot flashes in Denmark (unspecified route)